Cross-sectional study on the current status of palliative care in dermato-oncology
- Conditions
- C44Other malignant neoplasms of skin
- Registration Number
- DRKS00029195
- Lead Sponsor
- niversitätsklinikum MarburgKlinik für Dermatologie und AllergologieHauttumorzentrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Every skin cancer center and dermato-oncological outpatient clinic in the Federal Republic of Germany can participate
Exclusion Criteria
None
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main target criteria:<br>- How is palliative medicine included in the care of dermato-oncological patients?
- Secondary Outcome Measures
Name Time Method Secondary objective criteria:<br>- How many employees are trained in palliative care<br>- Is the topic of palliative care seen as relevant for daily work in dermato-oncology?
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are targeted in palliative care for C44 skin malignancies in DRKS00029195?
How does observational palliative care in dermato-oncology compare to standard-of-care symptom management for advanced skin cancers?
Which biomarkers correlate with improved quality of life in C44 patients receiving integrated palliative care?
What adverse events are commonly reported in dermato-oncology palliative care practices, and how are they managed?
Are there combination therapies or novel compounds being evaluated alongside palliative care for C44 skin tumors in recent studies?